section name header

Information

AHFS Class:

90:28.04.92 Polyclonal Antibodies, Miscellaneous

ATG (Equine) Lymphocyte Immune Globulin, Antithymocyte Globulin (Equine)

Products

Antithymocyte globulin (equine) is available as a 50-mg/mL concentrate for injection in 5-mL ampuls.4029 Each mL of solution contains equine thymocyte immune globulin 50 mg stabilized in 0.3 molar glycine.4029

The concentrate for injection should be diluted in an inverted bottle or bag of a compatible infusion to a concentration not exceeding 4 mg/mL.4029 The bottle or bag should be inverted during dilution so the concentrate does not come into contact with the air inside.4029 Gently rotate or swirl the diluted solution to mix.4029

pH

Approximately 6.8.4029

Trade Name(s)

Atgam

Administration

Antithymocyte globulin (equine) is administered by intravenous infusion into a vascular shunt, arterial venous fistula, or a high-flow central vein dilution in a compatible infusion solution.4029 The diluted solution should be at room temperature and should be administered through a 0.2- to 1-µm inline filter over a minimum of 4 hours.4029

Stability

Antithymocyte globulin (equine) is a transparent to slightly opalescent, colorless to faintly pink or faintly brown solution.4029 The solution may contain a slight granular or flaky deposit which the manufacturer states is normal.4029

Intact vials should be stored at 2 to 8°C in the original carton to protect from light.4029 Do not freeze.4029 Do not shake the concentrate or diluted solutions because excessive foaming and/or denaturation of the protein may occur.4029

Diluted solutions for infusion may be stored at room temperature and must be infused within 24 hours (including infusion time).4029

pH Effects

The manufacturer states diluting the concentrate in highly acidic solutions may contribute to physical instability over time.4029

Filtration

Diluted solutions for infusion should be administered through a 0.2- to 1-µm inline filter.4029

Compatibility

Solution Compatibility

Other Info

References

For a list of references cited in the text of this monograph, search the monograph titled References.

Copyrights

ASHP® Injectable Drug InformationTM. Selected Revisions December 5, 2024. © Copyright, 2025. American Society of Health-System Pharmacists®, 4500 East-West Highway, Suite 900, Bethesda, Maryland 20814.